10:56 AM EDT, 05/02/2024 (MT Newswires) -- Organon (OGN) reported Q1 adjusted earnings Thursday of $1.22 per diluted share, up from $1.08 a year earlier.

Analysts polled by Capital IQ expected $0.93.

Revenue for the quarter ended March 31 was $1.62 billion, up from $1.54 billion a year earlier. Four analysts surveyed by Capital IQ expected $1.56 billion.

Organon reaffirmed its 2024 revenue guidance of $6.20 billion to $6.50 billion. Analysts polled by Capital IQ expect $6.37 billion.

The pharmaceutical company maintained its quarterly dividend at $0.28 per share, payable June 13 to shareholders of record on May 13.

Organon shares were down nearly 3% in recent trading.

Price: 18.30, Change: -0.53, Percent Change: -2.81